MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma.
Curioni-Fontecedro A, Knights AJ, Tinguely M, Nuber N, Schneider C, Thomson CW, von Boehmer L, Bossart W, Pahlich S, Gehring H, Moch H, Renner C, Knuth A, Zippelius A.
Curioni-Fontecedro A, et al. Among authors: thomson cw.
Leukemia. 2008 Aug;22(8):1646-8. doi: 10.1038/leu.2008.43. Epub 2008 Mar 6.
Leukemia. 2008.
PMID: 18323799
No abstract available.